Screener
Veradermics MANE Business Segments — Other segment items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Veradermics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 5:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001827635-26-000019
| (in thousands) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other program candidates and expenses | — | 80 |
| Other unallocated research and development costs | ||
| Personnel expenses (including share-based compensation) | 3,476 | 879 |
| Other expenses | 85 | 84 |
| General and administrative, excluding personnel expenses | 4,608 | 1,050 |
| General and administrative, personnel expenses (including share-based compensation) | 4,329 | 418 |
| Other segment items(1) | (2,630) | (515) |
| Segment net loss | (27,232) | (12,400) |
Item 1. Condensed Consolidated Financial Statements (
FAQ
- What is Veradermics's business segments — other segment items?
- Veradermics (MANE) reported business segments — other segment items of -$2.63M in Q1 2026.
- How has Veradermics's business segments — other segment items changed year-over-year?
- Veradermics's business segments — other segment items decreased by 410.7% year-over-year, from -$515K to -$2.63M.
- What does business segments — other segment items mean?
- This metric captures miscellaneous financial items that do not fit into the primary research, development, or administrative categories. It often includes non-recurring charges, minor operational adjustments, or secondary income streams that impact the segment's bottom line. It serves as a catch-all for reconciling segment-level performance.
Ask your AI about Veradermics's business segments — other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude